๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Beijing
Clinical trial register · China

Clinical Trials in Beijing, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Peking Union Medical College Hospital276 Beijing Tiantan Hospital214 Cancer Institute and Hospital, Chinese Academy of Medical Sciences197 AstraZeneca183 Peking University People's Hospital158
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Beijing

5484 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Digital Remote Management Versus Usual Care for Optimization of Guideline-directed Medical Therapy in Patients With Heart Failure and Reduced Ejection Fraction: a Multicentre, Randomised, Controlled Trial (DigiCare-HFrEF)
NCT07352891Heart Failure With Reduced Ejection Fraction
Beijing Anzhen Hospital
Not applicable
252
Beijing, Dalian, Jilin City, Nanchang, Shanghai
2026-02-26
Recruiting
A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)]
NCT07331155Advanced Solid Tumour
Nanjing Leads Biolabs Co.,Ltd
Phase 2
110
Beijing, Anyang, Luoyang, Zhengzhou, Jinan, Suining
2026-02-26
Recruiting
Digital Remote Management for Care and Continuous Optimization Versus Usual Care to Reduce Risk of Atherosclerotic Cardiovascular Diseases (DigiCare-preASCVD)
NCT07332468Atherosclerotic Cardiovascular Diseases
Beijing Anzhen Hospital
Not applicable
564
Beijing, Changchun, Dalian, Nanchang, Shanghai
2026-02-25
Recruiting
Study on the Efficacy and Safety of Mecobalamin in Preventing Taxane-related Peripheral Neuropathy
NCT07423390Peripheral Neuropathy Due to Chemotherapy, Peripheral Neuropathy, Chemotherapy-induced
Qinghai Red Cross Hospital
Phase 3
326
Xining, Jinan, Beijing
2026-02-24
Recruiting
A Study of HDM1005 in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone
NCT07394114Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3
240
Beijing
2026-02-24
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
NCT07391657Relapsed Refractory Multiple Myeloma
AstraZeneca
Phase 3
508
Beijing, Changchun, Changsha, Chongqing, Guangzhou, Hefei, Nanchang, Nanjing
2026-02-23
Recruiting
Safety, Tolerability and Preliminary Efficacy of NEUK203-13 in Refractory Neuroendocrine Tumor Patients
NCT07366658SCLC, Extensive Stage, Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1
9
Beijing
2026-02-20
Recruiting
Phase II Study of CMS-D002 Capsule for Uterine Fibroids With Menorrhagia
NCT07402369Uterine Fibroids With Menorrhagia
Shenzhen Kangzhe Biotechnology Co., Ltd.
Phase 2
120
Beijing
2026-02-19
Recruiting
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
NCT07363590Systemic Lupus Erythematosus, Rheumatoid Arthritis
Merck Sharp & Dohme LLC
Phase 1
21
Beijing, Luoyang, Wuhan, Shanghai
2026-02-19
Recruiting
A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well
NCT07361302Acute Ischemic Stroke
Boehringer Ingelheim
Phase 3
1,325
Anyang, Baoji, Baotou, Beijing, Cangzhou, Changchun, Changsha, Chengdu
2026-02-17
By invitation
YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer
NCT07390565Extensive-stage Small Cell Lung Cancer (SCLC)
LI FENG
Not applicable
308
Beijing
2026-02-17
Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
NCT07220083Focal Segmental Glomerulosclerosis
Boehringer Ingelheim
Phase 3
286
Baotou, Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Lanzhou
2026-02-16
Recruiting
EIT-Guided Respiratory Physiotherapy for Prolonged Mechanical Ventilation (PMV)
NCT07372794Prolonged Mechanical Ventilation, Respiratory Failure, Critical Illness
Capital Medical University
Not applicable
200
Beijing
2026-02-16
Not yet open
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
NCT07317778Breast Cancer Early Stage Breast Cancer (Stage 1-3), HR Positive/HER2 Low Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
249
Beijing
2026-02-15
Recruiting
Application and Exploration of Personalized ctDNA-MRD Detection Technology in Predicting the Efficacy of Neoadjuvant Therapy for Rectal Cancer
NCT07393048Locally Advanced Rectal Cancer (LARC)
Beijing Friendship Hospital
Observational
60
Beijing
2026-02-15
Recruiting
Clinical Study of XNW5004 Tablets in the Treatment of Relapsed and Refractory Follicular Lymphoma
NCT07545603Follicular Lymphoma, Grade 1, Follicular Lymphoma, Grade 2, Follicular Lymphoma, Grade 3, Follicular Lymphoma Grade 3A
Evopoint Biosciences Inc.
Phase 2
65
Beijing
2026-02-14
Recruiting
Effects of a Preoperative Cognitive-Behavioral Intervention on Kinesiophobia and Function in Anterior Cruciate Ligament Reconstruction
NCT07423767Anterior Cruciate Ligament (ACL) Tear
Peking University Third Hospital
Not applicable
44
Beijing
2026-02-14
Recruiting
Study of the Efficacy and Safety of ICP-332 in Participants With Chronic Spontaneous Urticaria
NCT07378527Chronic Spontaneous Urticaria (CSU)
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 2/3
344
Bengbu, Wuhu, Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Luoyang
2026-02-13
Recruiting
Thiotepa-Containing Conditioning Regimen for Allogeneic HSCT in Chronic Myelomonocytic Leukemia
NCT07588594Chronic Myelomonocytic Leukemia (CMML)
Peking University People's Hospital
Not applicable
31
Beijing
2026-02-13
Recruiting
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
NCT07367516Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
105
Hefei, Beijing, Fuzhou, Lanzhou, Shantou, Nanning, Guangxi, Zunyi
2026-02-12
Recruiting
A Trial of SHR-A2102 With Adebrelimab in Locally Advanced or Metastatic Urothelial Carcinoma
NCT07393542Locally Advanced or Metastatic Urothelial Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
453
Beijing
2026-02-12
Not yet open
To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT07406438Neovascular Age-Related Macular Degeneration (nAMD)
Shenzhen Kexing Pharmaceutical Co., Ltd.
Phase 1
48
Beijing, Guiyang, Zhengzhou, Nanchang, Hangzhou
2026-02-12
Not yet open
Evaluation of the Efficacy of Red Light in Adult Patients With High and Extreme Myopia
NCT07412678Myopia
Beijing Tongren Hospital
Not applicable
128
Beijing
2026-02-12
Not yet open
Preoperative Hypofractionated RT + Immunotherapy & Surgery for Retroperitoneal Sarcoma (FUSION-02)
NCT07396116Soft Tissue Sarcoma (STS), Retroperitoneal Sarcoma, Immunotherapy, Radiotherapy Side Effect
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
28
Beijing
2026-02-12
Not yet open
Development of Bioluminescent Myopia Prevention and Control Instrument and Evaluation of Its Effect on Myopia
NCT07208617Myopia
Beijing Tongren Hospital
Not applicable
206
Beijing
2026-02-12
Recruiting
Givastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer (GIVA-2)
NCT07432295Solid Tumor, Advanced Cancer, Metastatic Cancer, Gastric Cancer
I-Mab Biopharma US Limited
Phase 2
180
Beijing
2026-02-11
Recruiting
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
NCT07363694Moderate to Severe Chronic Obstructive Pulmonary Disease
Pfizer
Phase 2/3
1,156
Chizhou, Fuyang, Hefei, Beijing, Guangzhou, Huizhou, Xinxiang, Hohhot
2026-02-11
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
NCT07369011Sleep Apnea, Obstructive, Obesity, Overweight
Eli Lilly and Company
Phase 3
800
Beijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hefei, Kunming
2026-02-10
Recruiting
IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer
NCT07377643HER2-positive Breast Cancer
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
Phase 3
540
Beijing
2026-02-10
Not yet open
Individualized Open Lung Ventilation and Postoperative Pulmonary Complications in Thoracic Surgery
NCT07387822Postoperative Pulmonary Complications (PPCs), One-lung Ventilation (OLV), Thoracic Surgery, Video Assisted
Aerospace Center Hospital
Not applicable
352
Beijing
2026-02-10
Recruiting
Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer
NCT07458529Rectal Cancer, Adenocarcinoma, Neoadjuvant Therapy, Immunotherapy, Probio-M9
Seventh Medical Center of PLA General Hospital
Phase 2
50
Beijing
2026-02-10
Not yet open
Phase 2 Clinical Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Platinum Chemotherapy Versus Platinum Chemotherapy in the Treatment of Second-/Third-line Triple Negative Breast Cancer (TNBC)
NCT07413601Triple Negative Breast Cancer Metastatic
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
78
Beijing
2026-02-10
Recruiting
Sonrotoclax Plus Dexamethasone With or Without Daratumumab Regimen in Patients With t(11;14) Primary AL Amyloidosis
NCT07335887AL Amyloidosis (AL), t(11;14) Positive
Peking University People's Hospital
Phase 2
39
Beijing, Xi'an
2026-02-10
Recruiting
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
NCT07227415Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer, Renal Neoplasm
Pfizer
Phase 1/2
224
Beijing, Chongqing, Wuhan, Changsha, Nanjing, Jinan, Ningbo
2026-02-10
Recruiting
NWRD09 for Persistent Cervical HPV16 Infection
NCT07710703Persistent Cervical HPV16 Infection
Newish Biotech (Wuxi) Co., Ltd.
Not applicable
60
Beijing
2026-02-10
Recruiting
Safety and Efficacy of Cryoablation for Thyroid Tumors
NCT07776262Thyroid Tumor, Thyroid Neoplasm
Yukun Luo
Not applicable
108
Beijing
2026-02-09
Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
NCT07353931Osteoarthritis, Overweight or Obesity
Eli Lilly and Company
Phase 3
900
Beijing, Bengbu, Changchun, Changsha, Chongqing, Hangzhou, Hefei, Jinan
2026-02-09
Recruiting
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
NCT07387094OSA - Obstructive Sleep Apnea, Obesity
Hangzhou Sciwind Biosciences Co., Ltd.
Phase 3
140
Beijing
2026-02-09
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
NCT07412756Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Beijing, Changsha, Chengdu, Guangzhou, Haidian District, Hefei, Huzhou, Jining
2026-02-09
Recruiting
The Value of Super-resolution Ultrasound Imaging for Peripheral Artery Disease
NCT07374601Peripheral Artery Disease
Peking University First Hospital
Observational
300
Beijing
2026-02-08
Recruiting
Advancing Reperfusion Therapy for Ischemic Stroke: Perfusion-guided Endovascular Intervention for Medium Vessel Occlusion Therapy
NCT07323368Stroke Ischemic, Medium Vessel Occlusions
Beijing Tiantan Hospital
Not applicable
568
Beijing, Longzhou, Luoyang, Panlong, Changle
2026-02-08
Recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
NCT07266441Multiple Myeloma
Janssen Research & Development, LLC
Phase 2
157
Beijing, Chaoyang District, Guangzhou, Shanghai
2026-02-08
Recruiting
A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis
NCT07399067Atopic Dermatitis
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
120
Beijing
2026-02-06
Recruiting
A Dose-exploration Study of EDP167 in HoFH
NCT07489209Homozygous Familial Hypercholesterolemia (HoFH)
Eddingpharm (Zhuhai) Co., Ltd.
Phase 2
20
Beijing
2026-02-06
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
NCT07321886Obesity, Overweight
Eli Lilly and Company
Phase 3
1,980
Beijing, Chengdu, Guangzhou, Hefei, Jinan, Luoyang Shi, Nanchang, Nanjing
2026-02-06
Not yet open
A Dose Finding Study of IBI3016 in Mild to Moderate Hypertensive Patients
NCT07352969Hypertension
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
352
Beijing
2026-02-06
Recruiting
A Study of MIL116 in Healthy Participants and Patients With IgA Nephropathy.
NCT07375758Immunoglobulin A Nephropathy
Beijing Mabworks Biotech Co., Ltd.
Phase 1/2
130
Beijing
2026-02-05
Recruiting
A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma
NCT07377578Mantle Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 3
394
Beijing, Nanning
2026-02-05
Active, closed
Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning
NCT07509632Rectal Cancers, Pathological Complete Response, Neoadjuvant Chemoradiotherapy, Machine Learning
Peking University People's Hospital
Observational
320
Beijing
2026-02-04
Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
NCT07258511Multiple Myeloma
Janssen Research & Development, LLC
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou
2026-02-04
Recruiting
A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
NCT07276958Healthy, Systemic Lupus Erythematosus, Rheumatoid Arthritis
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Not yet open
IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer
NCT07402070Resectable Stage II-III Non-small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 2
10
Beijing
2026-02-04
Recruiting
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer
NCT07325136Relapsed/Refractory Small Cell Lung Cancer
Bristol-Myers Squibb
Phase 1/2
240
Beijing, Shanghai
2026-02-03
Recruiting
Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy
NCT07656753Inherited Retinal Dystrophy, Inherited Retinal Disease
Peking Union Medical College Hospital
Phase EARLY_PHASE1
6
Beijing
2026-02-03
Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
NCT07431281Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer
AstraZeneca
Phase 3
2,130
Beijing, Changde, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-02-03
Recruiting
Arch-Clamping Technique Under Mild Hypothermia in Treating With Acute Type A Aortic Dissection
NCT07150559Acute Type A Aortic Dissection, Hypothermia, Total Aortic Arch Replacement, Frozen Elephant Trunk
Beijing Anzhen Hospital
Not applicable
306
Beijing
2026-02-03
Recruiting
Telemedicine-supported Management for Acute Ischemic Stroke
NCT07302971Acute Ischemic Stroke
Capital Medical University
Not applicable
2,400
Beijing
2026-02-02
Recruiting
Efficacy and Safety of YD0743 Treatment for Sepsis-Associated ARDS
NCT07413094Sepsis
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
Phase 2
309
Beijing
2026-02-02
Not yet open
Efficacy and Safety of LP-005 Injection in Patients With Complement-Mediated Kidney Disease
NCT07363265Complement-mediated Renal Diseases
Longbio Pharma
Phase 2
46
Beijing
2026-02-02
By invitation
Speaking Valve Trial vs. Capping Trial for Tracheostomy Decannulation in Prolonged Disorders of Consciousness
NCT07173634Prolonged Disorders of Consciousness
Hongying Jiang, MD
Not applicable
280
Beijing
2026-02-01
Not yet open
Objective Vascular Biomarkers as Triage for Depression in Chronic Atrophic Gastritis
NCT07319338Chronic Atrophic Gastritis, Depressive Symptoms, Depression, Gastrointestinal Diseases
China Academy of Chinese Medical Sciences
Observational
520
Beijing, Hengshui, Changzhou
2026-02-01
Recruiting
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
NCT07410039Neuromyelitis Optica Spectrum Disorder Attack
Chinese PLA General Hospital
Phase 4
200
Beijing
2026-02-01
Recruiting
Neoadjuvant Therapy With Tislelizumab for dMMR/MSI-H Stage II-III Colorectal Cancer
NCT07352280Colo-rectal Cancer (dMMR/MSI-H CRC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Observational
30
Beijing
2026-02-01
By invitation
A Voice Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness
NCT07183670Prolonged Disorders of Consciousness, Tracheostomy
Hongying Jiang, MD
Observational
184
Beijing
2026-02-01
Recruiting
A Single-arm Phase II Clinical Study of Camrelizumab Combined With Long-course Chemoradiotherapy for Total Neoadjuvant Therapy in Locally Advanced Low pMMR/MSS Rectal Cancer
NCT07527026Locally Advanced Rectal Cancer
Chinese PLA General Hospital
Phase 2
44
Beijing
2026-02-01
Not yet open
A Phase II Study of Anlotinib and Platinum-Based Chemotherapy in Patients With SMARCA4-Deficient, Locally Advanced or Metastatic Lung Cancer.
NCT07307443SMARCA4-Deficient Tumor, Locally Advanced or Metastatic Lung Cancer
Zhijie Wang
Phase 2
28
Beijing
2026-02-01
Not yet open
A Study of Postoperative Regional Nodal Radiotherapy in Intermediate-risk Breast Cancer
NCT07385365Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 3
3,142
Beijing
2026-02-01
Not yet open
VR Training to Improve Postoperative Cognitive Function in Elderly Patients With Cerebral Small Vessel Disease Undergoing Non-Cardiac Surgery
NCT07370844Cerebral Small Vessel Disease, Postoperative Cognitive Function
Peking University Third Hospital
Not applicable
240
Beijing
2026-02-01
Not yet open
Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes
NCT07063797Type 2 Diabetes, Osteoporosis, Fractures
Peking Union Medical College Hospital
Not applicable
358
Beijing, Huai'an, Jiangxi, Kunshan
2026-02-01
Not yet open
Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma
NCT07353554Multiple Myeloma (MM)
Peking Union Medical College Hospital
Not applicable
30
Beijing
2026-02-01
Not yet open
Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium
NCT07378371Pseudomyxoma Peritonei, Postoperative Delirium (POD)
Aerospace Center Hospital
Not applicable
174
Beijing
2026-02-01
Not yet open
INtensive liPid-lowering Therapy for Acute High-risk IntracRanial or Extracranial atheroSclerosis -II (INSPIRES-2)
NCT07341958Ischemic Stroke or High-risk TIA (ABCDยฒ โ‰ฅ 4)
Beijing Tiantan Hospital
Not applicable
242
Beijing
2026-02-01
Not yet open
The Efficacy and Safety of Microbiota Transplantation Combined With Prebiotics for Treatment of Functional Constipation
NCT07386795Constipation - Functional, Chronic Constipation, Fecal Microbiota Transplantation
Peking Union Medical College Hospital
Not applicable
19
Beijing
2026-02-01
Recruiting
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors
NCT07410676Cancer, Sarcoma, Leukaemia, Breast Cancer (Locally Advanced or Metastatic)
Essen Biotech
Phase 1/2
83
Beijing
2026-02-01
Not yet open
Portal Vein Thrombosis in Cirrhosis: Incidence, Outcomes and Anticoagulation
NCT07422701Portal Vein Thrombosis, Liver Cirrhosis
Peking University First Hospital
Observational
2,522
Beijing, Shenzhen, Hengshui, Qinhuangdao, Wuxi, Qingdao
2026-02-01
Recruiting
5T MRI and Metabolomics-Based Hemorrhage Risk Prediction in Moyamoya Disease
NCT07781579Moyamoya Disease, Intracranial Hemorrhages, Stroke
Beijing Hospital
Observational
500
Beijing
2026-02-01
Recruiting
Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
NCT07410494Cancer, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (Locally Advanced or Metastatic)
Essen Biotech
Phase 1/2
85
Beijing
2026-02-01
By invitation
Clinical Efficacy of Exoskeleton Robot-Assisted Rehabilitation on Lower Limb Functional Recovery in Elderly Patients With Hip Fracture
NCT07323147Hip Fracture, Geriatrics, Lower Extremity Dysfunction, Postoperative Rehabilitation
Hai bao
Not applicable
86
Beijing
2026-02-01
Not yet open
Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy
NCT07276919Acute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)
Peking University First Hospital
Phase 4
1,844
Beijing
2026-02-01
Not yet open
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE๏ผ‰
NCT07274137Overweight or Obesity
MindRank AI Ltd
Phase 3
738
Beijing, Changchun, Changde, Changsha, Datong, Dongyang, Ganzhou, Hefei
2026-02
Recruiting
Safety and Efficacy of the RENATUSยฎ Transcatheter Aortic Valve System for the Treatment of Severe Aortic Stenosis
NCT07414342Severe Aortic Stenosis
Beijing Balance Medical Technology Co., Ltd
Not applicable
800
Beijing
2026-02
Not yet open
NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC
NCT07412171Upper Tract Urothelial Carcinoma
Peking University Third Hospital
Phase 2
40
Beijing
2026-02
Recruiting
Response-Based Local Therapy for Regionally Advanced Breast Cancer
NCT07376538Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
157
Beijing
2026-02
Recruiting
Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastrointestinal Cancer
NCT07329894Gastrointestinal Cancer
Beijing GoBroad Hospital
Phase 1
18
Beijing
2026-02
Not yet open
IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma
NCT07355283Relapsed/Refractory Follicular Lymphoma
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Phase 3
198
Beijing
2026-02
Not yet open
AI-Generated Video Feedback to Improve Technical Skills in Coronary Artery Bypass Grafting
NCT07400172Cardiac, Surgery (Cardiac), Education, Artificial Intelligence (AI)
China National Center for Cardiovascular Diseases
Not applicable
100
Beijing
2026-01-31
Recruiting
Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors.
NCT07448116Solid Advanced Tumor
Betta Pharmaceuticals Co., Ltd.
Phase 1/2
164
Beijing
2026-01-31
Not yet open
Development and Validation of a Cardiac Magnetic Resonance-Based Multimodal Deep Learning Model for Long-Term Outcome Prediction in ST-Segment Elevation Myocardial Infarction
NCT07277400ST Elevation (STEMI) Myocardial Infarction
Qian geng
Observational
800
Beijing
2026-01-31
Active, closed
A Study of Remternetug (LY3372993) in Healthy Chinese Participants
NCT07346495Healthy
Eli Lilly and Company
Phase 1
24
Beijing, Xuhui District
2026-01-31
Not yet open
The Effect of Speaking Valve on Physiological Parameters With Wearable Devices
NCT07422350Tracheostomy Decannulation
Jingyi Ge
Observational
120
Beijing
2026-01-31
Recruiting
Zorifertinib With Osimertinib for NSCLC With Meningeal Progression
NCT07361705Patients With Advanced Non-small Cell Lung Cancer With Meningeal Progression After Osimertinib Treatment
Alpha Biopharma (Jiangsu) Co., Ltd.
Phase 1
42
Beijing, Shengyang, Guangzhou, Henan, Shanxi
2026-01-31
Not yet open
Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD
NCT07357532Small Cell Lung Carcinoma
Peking University Cancer Hospital & Institute
Phase 2
44
Beijing
2026-01-31
Not yet open
A Phase I Platform Study of Target-Based Screened CAR-Macrophages for the Treatment of Advanced Malignant Tumors
NCT07409766Advanced Malignant Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1
20
Beijing
2026-01-31
Recruiting
Basilar Artery Occlusion Chinese Endovascular Registry in Patients With Large-Core Infarct
NCT07345702Basilar Artery Occlusion, Ischemic Stroke, Large Core Infarct
Xuanwu Hospital, Beijing
Observational
518
Beijing
2026-01-31
Recruiting
Intrauterine Injection of Type III Collage in FST of EC/AEH
NCT07377734Atypical Endometrial Hyperplasia, Endometrial Cancer
Wang Jianliu
Phase 2
30
Beijing
2026-01-30
Not yet open
Isa-VRD in TIE HRMM
NCT07334535Multiple Myeloma
Peking Union Medical College Hospital
Phase 4
117
Beijing
2026-01-30
Recruiting
Jiedu Huayu Oral Prescription in the Treatment of Intracranial Hemorrhage Associated With Cerebral Amyloid Angiopathy
NCT07250035Cerebral Amyloid Angiopathy
Beijing Tiantan Hospital
Phase 3
436
Beijing
2026-01-30
Not yet open
Motor Development Assessment and Support for Children With Neurodevelopmental Disorders
NCT07323004Neurodevelopmental Disorders
Aiyoudong Children and Youth Sports Health Research Institute
Not applicable
100
Beijing
2026-01-30
Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
NCT07288177Non-small Cell Lung Cancer (NSCLC)
Genmab
Phase 2
240
Shanghai, Beijing, Tianjin, Zhangjiakou, Zhengzhou
2026-01-30
Not yet open
Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia
NCT07382921Fibromyalgia, Pregabalin, Pain
Beijing Tiantan Hospital
Not applicable
164
Beijing
2026-01-30
Rows per page Showing 1001–1100 of 5484
Previous 9 10 11 12 13 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/beijing?page=11

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 5,484 of those studies with a site in Beijing.

How many clinical trials are recruiting in Beijing?

3,341 of the 5,484 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 966 have not yet opened recruitment, 1,001 are active but closed to new participants, and 176 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.